Effects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trials.

Domalpally, Amitha; Ip, Michael S; Ehrlich, Jason S

Domalpally, Amitha; Ip, Michael S; Ehrlich, Jason S.

Affiliation

Domalpally A; Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison, Wisconsin.
Ip MS; Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison, Wisconsin. Electronic address: msip@wisc.edu.
Ehrlich JS; Genentech, Inc., South San Francisco, California.

Ophthalmology ; 122(4): 779-86, 2015 Apr.

Article in En | MEDLINE | ID: mdl-25601535

Subject(s)

Angiogenesis Inhibitors/therapeutic use; Antibodies, Monoclonal, Humanized/therapeutic use; Diabetic Retinopathy/drug therapy; Macular Edema/drug therapy; Retinal Vessels/drug effects; Subretinal Fluid/drug effects; Adult; Aged; Capillary Permeability; Diabetic Retinopathy/physiopathology; Double-Blind Method; Female; Fovea Centralis/pathology; Humans; Intravitreal Injections; Macular Edema/physiopathology; Male; Middle Aged; Ranibizumab; Retinal Vessels/pathology; Vascular Endothelial Growth Factor A/antagonists & inhibitors; Visual Acuity/physiology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Retinal Vessels / Macular Edema / Angiogenesis Inhibitors / Diabetic Retinopathy / Subretinal Fluid / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2015 Type: Article

Fulltext

XML

PubMed Links

Search on Google